[1] University of Kansas Medical Center,Department of Pathology and Laboratory Medicine
[2] National Institutes of Health,Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute
[3] Ohio State University,Comprehensive Cancer Center, Department of Health Sciences
[4] Hospitalet de Llobregat,Program in Molecular Mechanisms and Experimental Therapy in Oncology, IDIBELL
[5] Federal University of Bahia,Department of Pathology, Prof. Edgard Santos Teaching Hospital
[6] Institut Necker-Enfants Malades,Lymphoid Malignancies Branch, Center for Cancer Research
[7] Institut National de la Santé et de la Recherche Médicale U1151,Division of Oncology, Department of Medicine
[8] Laboratoire Onco-Hématologie,Unité d’épidémiologie et de Physiopathologie des virus Oncogene
[9] National Cancer Institute,Laboratory of Virus Control
[10] National Institutes of Health,Department of Hematology, Rheumatology, and Infectious Disease, Graduate School of Medical Sciences, Faculty of Life Sciences
[11] Washington University,Department of Hematology/Oncology, IMSUT Hospital
[12] Université de Paris (Descartes),undefined
[13] Institut Necker-Enfants Malades,undefined
[14] Institut National de la Santé et de la Recherche Médicale (INSERM) U1151 Laboratoire Onco-Hematology,undefined
[15] Institut Pasteur,undefined
[16] Centre National de la Recherche Scientifique (CNRS) UMR 3569,undefined
[17] Institute for Frontier Life and Medical Sciences,undefined
[18] Kyoto University,undefined
[19] Kumamoto University,undefined
[20] The Institute of Medical Science,undefined
[21] The University of Tokyo,undefined